Feed / WGRX

Wellgistics Health Inc

WGRX

Healthcare · 2.93 -17.5% today

Isolated · not yet confirmedMarket checked 14 Jul, 15:55 GMT-4

Market read

Wellgistics Health Inc's current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 21 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.

Company-17.5% todayVolume comparison unavailable
Market group0 of 21 activeRenewable Energy & Metals · unavailable
Disclosed network0 of 4 confirmingNo filing-linked name is confirming now
What would change this read
  • WGRX's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if WGRX's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Medical Distribution

No new filing conclusion is available. 0 of 21 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • WGRX's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods2
Price observations289
Usable filing statements77
Verified relationships4
Evidence supporting the case
  • Latest annual revenue changed +28.7% year over year.
Evidence challenging the case
  • Operating margin changed -367.8 percentage points in the latest annual period.
  • Net margin changed -396.1 percentage points in the latest annual period.
  • Credit and interest rates has repeated adverse evidence across 3 filings.
Questions before a position
  • EV/sales is 3419% above the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Jul 29, 2026

3.03
6m+624.9%12m+256.5%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2024-12-31$18.1M$-0.15
2025-12-31$23.3M+28.7%$-1.43

What management says matters

Persistent and emerging business drivers

Credit and interest ratesnegative · 3 filings
The improvement was primarily driven by the reduction in non-cash stock-based compensation expense of approximately $27.0 million, partially offset by lower gross profit and higher interest expense during the period.
10-Q · May 19, 2026
Demand and volumenegative · 2 filings
The decrease was primarily driven by a significant decline in distribution revenues within the Wellgistics, LLC, reflecting the impact of liquidity constraints that limited the Company’s ability to procure and fulfill product orders during the period.
10-Q · May 19, 2026
Restructuring and cost reductionsmixed · 2 filings
The decrease was primarily attributable to the impairment of goodwill and intangible assets recognized during the year ended December 31, 2025.
10-Q · May 19, 2026
Legal and regulatory exposuremixed · 1 filings
Revenue driven by this model will be derived from pharmaceutical manufacturers and other strategic channel partners paying for the following services: patient care coordination, clinical services, compliance and persistency programs, patient financial assista…
10-K · Mar 20, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 9.2× · EV/sales 9.8×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Fewer than 4 annual revenue periods; too little history to scaffold scenarios.

Price action

How the market is pricing the story

2.93-17.5% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 14 Jul, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for WGRX. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for WGRX. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind WGRX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

LYFTLyft, Inc.distributorMar 20, 2026

Through our application and with our integrated pharmacy partners, DelivMeds’ is able to provide the end-to-end solution, assisting with co-pay collection, providing 100% pass through to DelivMeds’ integrated partner pharmacies, and arranging for the delivery…

AMZNAmazon.com, Inc.competitorMar 20, 2026

The competitive healthcare landscape along with macroeconomic pressures has also seen increased chapter 11 filings for bankruptcy and or other means of dissolution including Medley, NowRx, AmazonCare, Haven (i.e., joint venture of Amazon, Berkshire Hathaway,…

BRK-BBerkshire Hathaway Inc.competitorMar 20, 2026

The competitive healthcare landscape along with macroeconomic pressures has also seen increased chapter 11 filings for bankruptcy and or other means of dissolution including Medley, NowRx, AmazonCare, Haven (i.e., joint venture of Amazon, Berkshire Hathaway,…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

WGRX is currently a Follower in the organic co-movement group Renewable Energy & Metals. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for WGRX; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.